Read More 1 minute read Analyst Ratings News Upgrades Janney Montgomery Scott Upgrades HomeTrust Bancshares to Buy By Benzinga Newsdesk February 21, 8:19 AM Janney Montgomery Scott analyst Feddie Strickland upgrades HomeTrust Bancshares (NASDAQ:HTBI) from Neutral to Buy. HTBI
Read More 1 minute read Analyst Ratings News Price Target Upgrades Raymond James Upgrades Glacier Bancorp to Outperform, Announces $51 Price Target By Benzinga Newsdesk February 21, 8:17 AM Raymond James analyst Michael Rose upgrades Glacier Bancorp (NYSE:GBCI) from Market Perform to Outperform and announces $51 price target. GBCI
Read More 1 minute read Analyst Ratings News Price Target Upgrades Raymond James Upgrades Trustmark to Outperform, Announces $34 Price Target By Benzinga Newsdesk February 21, 7:39 AM Raymond James analyst Michael Rose upgrades Trustmark (NASDAQ:TRMK) from Market Perform to Outperform and announces $34 price target. TRMK
Read More 1 minute read Analyst Ratings News Price Target Upgrades Raymond James Upgrades Lakeland Financial to Outperform, Announces $78 Price Target By Benzinga Newsdesk February 21, 7:37 AM Raymond James analyst David Long upgrades Lakeland Financial (NASDAQ:LKFN) from Market Perform to Outperform and announces $78 price target. LKFN
Read More 1 minute read Analyst Ratings News Price Target Upgrades B. Riley Securities Upgrades MarineMax to Buy, Raises Price Target to $52 By Benzinga Newsdesk February 21, 7:17 AM B. Riley Securities analyst Eric Wold upgrades MarineMax (NYSE:HZO) from Neutral to Buy and raises the price target from $33 to $52. HZO
Read More 1 minute read Analyst Ratings News Price Target Upgrades Wolfe Research Upgrades Norfolk Southern to Outperform, Announces $255 Price Target By Benzinga Newsdesk February 21, 7:15 AM Wolfe Research analyst Scott Group upgrades Norfolk Southern (NYSE:NSC) from Peer Perform to Outperform and announces $255 price target. NSC
Read More 1 minute read Analyst Ratings News Price Target Upgrades Goldman Sachs Upgrades Vir Biotechnology to Buy, Raises Price Target to $53 By Benzinga Newsdesk February 21, 5:44 AM Goldman Sachs analyst Paul Choi upgrades Vir Biotechnology (NASDAQ:VIR) from Neutral to Buy and raises the price target from $41 to $53. VIR
Read More 2 minute read Analyst Ratings Movers News Price Target Trading Ideas Upgrades Coinbase Will Transcend Crypto Winter Backed By Recovering Trading And Staking Business Opportunities In 2H: Analyst By Anusuya Lahiri February 17, 2:02 PM Compass Point analyst Chris Allen upgraded Coinbase Global Inc (NASDAQ: COIN) from Neutral to Buy and COIN
Read More 1 minute read Analyst Ratings News Price Target Upgrades BTIG Upgrades DraftKings to Buy, Announces $24 Price Target By Benzinga Newsdesk February 17, 7:45 AM BTIG analyst Clark Lampen upgrades DraftKings (NASDAQ:DKNG) from Neutral to Buy and announces $24 price target. DKNG
Read More 1 minute read Analyst Ratings News Price Target Upgrades DZ Bank Upgrades Cisco Systems to Buy, Announces $100 Price Target By Benzinga Newsdesk February 17, 7:41 AM DZ Bank analyst Ingo Wermann upgrades Cisco Systems (NASDAQ:CSCO) from Hold to Buy and announces $100 price target. CSCO